Reported 4 months ago
Investing in dividend stocks requires consideration beyond high yields; Pfizer is recommended for its resilience. Despite recent challenges, Pfizer remains a strong choice for long-term investors due to its commitment to innovation and financial stability. With a history of dividend increases and a forward dividend yield of 5.87%, Pfizer's dedication to shareholders and promising growth prospects make it a favorable investment option, especially in uncertain market conditions.
Source: YAHOO